Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyan Yu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
NMR in Biomedicine|March 6, 2026
Therapeutic Effects Assessment in Acute Lung Injury Using Hyperpolarized <sup>129</sup>Xe Magnetic ResonanceYu Zheng, Haidong Li, Ming Zhang, et al.
European Journal of Medicinal Chemistry|January 28, 2015
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approachesBoshi Huang, Cuicui Li, Wenmin Chen, et al.
Immunogenetics|August 13, 2016
Rapid identification of bovine MHCI haplotypes in genetically divergent cattle populations using next-generation sequencingDeepali Vasoya, Andy Law, Paolo Motta, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung developmentYan Geng, Yingying Dong, Mingyan Yu, et al.
Structure (London, England : 1993)|August 21, 2012
Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selectionCho Yeow Koh, Jessica E Kim, Sayaka Shibata, et al.
Journal of Hepatology|February 8, 2024
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapyRong Xiao, Ye Tian, Jiwei Zhang, et al.
Science Translational Medicine|November 15, 2023
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse modelsShuaiya Ma, Ye Tian, Jiali Peng, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
NMR in Biomedicine|March 6, 2026
Therapeutic Effects Assessment in Acute Lung Injury Using Hyperpolarized <sup>129</sup>Xe Magnetic ResonanceYu Zheng, Haidong Li, Ming Zhang, et al.
European Journal of Medicinal Chemistry|January 28, 2015
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approachesBoshi Huang, Cuicui Li, Wenmin Chen, et al.
Immunogenetics|August 13, 2016
Rapid identification of bovine MHCI haplotypes in genetically divergent cattle populations using next-generation sequencingDeepali Vasoya, Andy Law, Paolo Motta, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung developmentYan Geng, Yingying Dong, Mingyan Yu, et al.
Structure (London, England : 1993)|August 21, 2012
Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selectionCho Yeow Koh, Jessica E Kim, Sayaka Shibata, et al.
Journal of Hepatology|February 8, 2024
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapyRong Xiao, Ye Tian, Jiwei Zhang, et al.
Science Translational Medicine|November 15, 2023
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse modelsShuaiya Ma, Ye Tian, Jiali Peng, et al.
Pageof 3